QRONS (QRON) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 12 20 sessions, May 19, 2025 to May 27, 2026
- Largest daily move
- +123.3% close of July 17, 2025
- 1-year change
- -92.1% closing prices, May 19, 2025 to May 27, 2026
- 5-year change
- -97.5% closing prices, May 27, 2021 to May 27, 2026
Company Description
QRONS (OTC: QRON) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $1.2M.
QRON has declined 92.1% over the past year. The last closing price was $0.0111.
For FY2024, QRONS reported revenue of $0 and diluted earnings per share of $0.00.
This page collects what Stock Titan holds for QRON, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
QRONS (QRON) closed at $0.0111 on May 27, 2026. Over the past 12 months, the price has lost 92.1%.
QRON Metrics & Rankings
Price returns through May 27, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
QRONS has 10 recent news articles. Of the recent coverage, 1 article coincided with positive price movement and 1 with negative movement. Key topics include management, clinical trial. View all QRON news →
SEC Filings
QRONS has filed 3 recent SEC filings, including 2 Form 8-K, 1 Form 15-12G. The most recent filing was submitted on August 14, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all QRON SEC filings →
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
QRON Company Profile & Sector Positioning
QRONS (QRON) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing QRON often look at related companies in the same sector, including Regen Biopharma (RGBPP), Halberd Corp (HALB), Evofem Bioscienc (EVFM), Ayala Pharm (ADXS), and Ocean Biomedical Inc. (OCEA). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate QRON's relative position within its industry.